Submitted by Anonymous (not verified) on 30 October 2026 - 9:06
Human medicines European public assessment report (EPAR): Oxlumo, lumasiran, Date of authorisation: 19/11/2020, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oxlumo, lumasiran, Date of authorisation: 19/11/2020, Revision: 7, Status: Authorised